Post-operative Lite Run Study

February 18, 2021 updated by: Joyce Trost, Gillette Children's Specialty Healthcare

Post-operative Use of Lite Run in a Pediatric Population With Cerebral Palsy

Lite Run is a new assistive device that may have FDA listing as a Class I device by mid 2017 based on clinical testing of adults, independent agency testing and in-house evaluations.

This will be a combined study with multiple purposes with respect to the evaluation of its use with the post-operative pediatric population. A first purpose is to verify safety and feasibility of the device on pediatric patients. A second purpose is to statistically test the effectiveness of Lite Run to decrease physical burden on the therapist during post-operative gait training for children and adolescents with cerebral palsy as compared to current methods of body weight-supported gait training. A third purpose is to measure and qualitatively evaluate the effectiveness of the device on patient outcomes and improving patient and therapist satisfaction.

Study Overview

Detailed Description

Background Cerebral palsy (CP) refers to a group of disorders affecting movement and is attributable to a non-progressive injury to the developing brain. CP is the most common cause of physical disability in childhood with a prevalence of 3.1 - 3.6 per 1000 births. At this prevalence, we estimate that over 300,000 children under 21 in the US have CP. Children with CP have a variety of neuro-motor impairments including muscle weakness and abnormal muscle tone that leads to progressive musculoskeletal impairments over time. These children experience discomfort and limitations in functional mobility such as walking (ambulation) that severely impact their quality of life. Surgical intervention is often used to improve ambulation quality and quantity for children with cerebral palsy anytime from childhood into adulthood. Depending on treatment goals, it is not unusual for an individual with cerebral palsy to undergo surgery involving muscles, tendons, bones or nerves of the feet, ankles, legs or hips. Two common surgical interventions for ambulatory children with cerebral palsy include single event multilevel orthopedic surgery to correct muscle lengths and bone alignment, and selective dorsal rhizotomy to decrease spasticity. Post-operative treatment course varies depending on the child's condition, pre-operative functional level, and specific surgical intervention selected to improve their particular deficiencies. Post-orthopedic surgery, children may be non-weight-bearing for 2-6 weeks. After selective dorsal rhizotomy, patients exhibit surgical site instability and significant trunk and leg weakness. They are non-weight-bearing for 2-4 weeks post-surgically, and may begin to stand and walk once cleared by the physician.

When beginning mobility training after orthopedic or selective dorsal rhizotomy surgery, children typically demonstrate significant weakness and can experience fear, pain and anxiety as they begin to move. One aspect of mobility that is a significant milestone for children post-surgically is getting back up and walking. The process to get back up and walk is facilitated by physical therapists and is termed "gait training" which includes the components of moving from sit to stand, bearing weight through the lower limbs, taking steps, and returning to a sitting position. Body weight-supported gait training is often used in therapy for adults and children to ease the transition from non-weight-bearing back to being able to walk at their previous level of gait function. Support during this transition may be provided by a physical therapist using a gait belt, a harness system attached to an overhead track or device to support body weight, or other assistive devices. Current body weight support systems for gait training are not optimal. Also there are reports in the literature of difficulties with harness discomfort and donning and doffing. An unpublished survey of twelve physical therapists was conducted by a University of Minnesota PT student who was able to identify 20 deficiencies in available devices for body weight supported gait training. More than 50% of the therapists cited the following sub-optimal aspects from their experiences:

  • Therapist providing majority of the body weight support when using a gait belt takes away from therapeutic touch for gait therapy
  • Current harness devices cannot adjust the percent of how much support the device gives
  • There is not sufficient therapeutic evidence for the efficacy of current body weight support devices
  • Current harness devices do not feel like they will help us prevent injury.
  • Current body weight support devices only work in limited applications

Using physical therapist support for gait training without a body weight support device can require multiple people to assist, result in fatigue, and has the potential of injury for the therapist. In a survey of physical therapists working in rehabilitation facilities, 67% reported musculoskeletal pain or discomfort within the past year. Half reported that patient repositioning (49%) and gait training (47%) also caused or contributed to their pain. Another study reports survey results of over 1,000 occupational and physical therapists. The survey indicated that functional activities such as gait training and settings such as pediatric rehabilitation were associated with injury. An ergonomic analysis of physical therapists working in rehabilitation concluded that physical therapists are at high risk for work related musculoskeletal injuries while performing sit-to-stand transfers and overground gait training.

To improve gait training therapy for both therapist and patient and to reduce a therapist's need to lift and support the body weight of a patient, Lite Run Inc. has developed the Lite Run Gait Trainer (Lite Run). Lite Run is a new system for the treatment of patients with gait and balance difficulties that uses differential air pressure inside a specially designed lower body suit to effectively reduce up to 50 percent of a patient's body weight. The suit is similar to a pair of pants in appearance and is as easy to don and doff as a pair of pants. The suit uses technology like astronaut spacesuits to achieve comfort and flexibility while providing a unique "unweighting" effect that facilitates patient ambulation from sitting through taking steps. The suit is used in conjunction with the Lite Run Gait Trainer, which provides air pressure to the suit and support for the patient.

Lite Run features include: (1) control for the amount of body weight support (up to 50% of the patient's weight), (2) electro-mechanical and pneumatic controls for providing assistance in transferring the patient from sitting to standing and ambulation, (3) an open design that permits access to a patient's body and legs by the therapist, (4) a compact profile that provides easy maneuverability, and (5) a "base spread" function that permits positioning close to a patient when seated in a wheelchair, bed or therapy table.

Together, these features provide safety and stability for the patient and reduced physical burden on the therapist while improving the gait training experience and potentially preventing patient or therapist injury. The system also frees the therapist to focus on skilled therapeutic activities because the patient is secure in the system.

Lite Run conducted a product demonstration and pediatric needs survey for six physical therapists at Gillette Children's Specialty Healthcare. Current support devices used for training include overhead harness supports, robotic systems, and harness gait trainers. Therapists indicated that current devices can be uncomfortable, cause patients to "hang" on the support, and limit natural motion during sit-to-stand and walking. Gait trainers and walking devices provide trunk and pelvic support using a seat or harness, and are used with a treadmill which can be both uncomfortable and scary for children right out of surgery.

Lite Run may have FDA listing as a Class I device by mid 2017 based on adult clinical feasibility testing, and completion of independent agency testing and in-house evaluations. A clinical safety and feasibility trial for adult patients was performed at the Rehabilitation Center at North Memorial Medical Center, Robbinsdale, MN with 18 adults with a range of neurological conditions.

Adult physical therapists participating in this trial have indicated the following:

  • Lite Run is comfortable. Harnesses at the groin are uncomfortable for many patients. Lite Run has the potential to decrease pain, and improve security, support, compression, adjustability, and flexibility in combination with support. It provides improved mobility during sit-to-stand. The device may allow the patient to get back up walking sooner after surgery than if they were using another device.
  • It is easy for therapists to use. Pants donning time is less than 5 minutes, and requires two quick attach points to engage the patient into the device. It is easily adjustable.
  • It decreases the burden on the therapist. Because the device supports the patient's body weight, therapists hands are free to provide cuing and facilitation rather than physical support. It could prevent therapist injury particularly to the back. It is fall proof.
  • The device is able to quantify the amount of support provided.

The results of this study indicated that there were no adverse events or safety issues from using the system on adults. In addition to safety and feasibility testing, the following user design requirements were tested: time to don liner and pants, transfer-in time, therapist's access to patient, patient's arm mobility, hindrance of patient's stride, patient directed steerability, brake stability, overall stability, sit-to-stand functionality, wheelchair compatibility, sit-to-stand sufficiency, odometer acceptability, ease of use, and the physical effort required by the PT. After training, all therapists were all able to operate the Lite Run safely and independently. The device allowed them to use their hands to provide skilled therapeutic maneuvers, as the device provided stability and patient unweighting. The study demonstrated that the Lite Run is a safe system and shows potential for pediatric application to improve the rehabilitation experience and outcomes. Therefore, continued investigation regarding the feasibility of using the device in a post-operative pediatric population using pediatric sized lower body pressure suits is warranted.

Study Type

Interventional

Enrollment (Actual)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Minnesota
      • Saint Paul, Minnesota, United States, 55101
        • Gillette Children's Specialty Healthcare

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

4 years to 17 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • diagnosis of cerebral palsy, neurologic syndrome, chromosomal abnormalities, spina bifida, or other neurological disorders
  • age 4-17
  • recent single event multilevel lower extremity orthopedic surgery or selective dorsal rhizotomy
  • referred for physical therapy for mobility/gait training to regain functional walking and ambulation

Exclusion Criteria:

  • Gross Motor Function Classification System levels I (walk and run in the community with only limitations in balance, coordination and speed) and V (use wheelchair to maintain sitting and for whole body mobility) prior to surgical intervention
  • Subjects who are too large or too small to fit within the current Lite Run pants/prototype. The minimum patient weight is 50 lbs. The maximum patient weight is 350 lbs.
  • Subjects that do not have clearance for full weight-bearing at the first treatment session

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Device Feasibility
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Lite Run Gait Trainer
Participants will be using the Lite Run Gait Trainer to assist them in weightbearing and walking after SDR or SEMLS surgery.
Lite Run is a new system for the treatment of patients with gait and balance difficulties that uses differential air pressure inside a lower body suit to reduce up to 50 percent of a patient's body weight. The suit is similar to a pair of pants in appearance and is as easy to don and doff as a pair of pants. The suit uses technology like astronaut spacesuits to achieve comfort and flexibility while providing a unique "unweighting" effect that facilitates patient ambulation from sitting through taking steps. The suit is used in conjunction with the Lite Run Gait Trainer, which provides air pressure to the suit and support for the patient.
Other Names:
  • Lite Run
  • DHF No: 55-0001, 55-0002 & 55-0003
Placebo Comparator: Usual Treatments
Participants will be using current treatments used in clinical practice to assist them in weightbearing and walking after SDR or SEMLS surgery.
The usual clinical treatments (standard of care treatments) will be used to assist patients in weightbearing and walking.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of subjects with treatment-related adverse events as assessed by CTCAE v, 4.
Time Frame: Through study completion, up to 60 days
Adverse events will be tracked for each subject enrolled in the study.
Through study completion, up to 60 days
Number of Pass or Fail grades for setting up the Lite Run device
Time Frame: Through study completion, up to 60 days
This measure will look at how easy Lite Run is to set up with a Pass or Fail grade by a trained Observer.
Through study completion, up to 60 days
Reduction of physical assistance by study Physical Therapists as assessed by the ordinal scale for the Walk item of the WeeFim II ® Locomotion subscale
Time Frame: Through study completion, up to 60 days
This measure will look at whether use of the Lite Run device will decrease the physical assistance needed for ambulation compared to standard of care treatments.
Through study completion, up to 60 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Reduction of physical assistance for sit-to-stand mobility for participants assessed by the ordinal scale 1-6 for the Transfer: Chair item of the WeeFIM II® Transfer subscale
Time Frame: Through study completion, up to 60 days
The will measure the amount of physical assistance needed for the sit-to-stand motion during physical therapy.
Through study completion, up to 60 days
Increased duration of therapeutic weight-bearing activities in minutes
Time Frame: Through study completion, up to 60 days
A trained observer will document the number of minutes spent doing weightbearing activities during study visits to see if there is an increase when using the Lite Run device.
Through study completion, up to 60 days
Reduction of Pain during physical therapy for Non-Verbal children assessed by the Non-communicating Children's Pain Check List - Postoperative Version
Time Frame: Through study completion, up to 60 days
Pain during study Visits will be assessed with the Non-communicating Children's Pain Check List - Postoperative Version for any children who are non-verbal. It is hypothesized that pain will be reduced when the Lite Run device is used during therapy.
Through study completion, up to 60 days
Reduction of Pain during physical therapy for Children
Time Frame: Through study completion, up to 60 days
Pain during the study Visits will be assessed with the Visual Analog Pain Scale. It is hypothesized that pain will be reduced when using the Lite Run device during therapy.
Through study completion, up to 60 days
Reduction of Anxiety levels during therapy for children ages 8 to 17 years will be assessed with the Visual Analog Anxiety Scale .
Time Frame: Through study completion, up to 60 days
Anxiety will be measured at each study visit with the Visual Analog Anxiety Scale. It is hypothesized that anxiety will be reduced when using the Lite Run device during therapy.
Through study completion, up to 60 days
Reduction of Anxiety levels during therapy for children ages 4-7 years will be assess with the Children's Fear Scale "Scared".
Time Frame: Through study completion, up to 60 days
Anxiety will be measured at each study visit with the Children's Fear Scale "Scared". It is hypothesized that anxiety will be reduced when using the Lite Run device during therapy.
Through study completion, up to 60 days
Participant Satisfaction will be measured after each therapy visit with the QUEST Version 2.0 will be used, focusing on the first eight questions.
Time Frame: Through study completion, up to 60 days
Participant satisfaction with their therapy will be measured with the QUEST Version 2.0 will be used, focusing on the first eight questions. We hypothesize that participants will have a higher satisfaction score when the Lite Run device is used at their therapy visit
Through study completion, up to 60 days
Therapist Satisfaction will be measured after each therapy visit with the QUEST Version 2.0 will be used, focusing on the first eight questions.
Time Frame: Through study completion, up to 60 days
Therapist satisfaction with the participants therapy will be measured using the QUEST Version 2.0 will be used, focusing on the first eight questions. We hypothesize that therapists will have a higher satisfaction score when the Lite Run device is used during the therapy visit.
Through study completion, up to 60 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Joyce Trost, PT, Gillette Children's Specialty Healthcare
  • Principal Investigator: John Hauck, Lite Run Inc.
  • Principal Investigator: Doug Johnson, Lite Run Inc.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 15, 2017

Primary Completion (Actual)

September 15, 2019

Study Completion (Actual)

September 15, 2019

Study Registration Dates

First Submitted

March 22, 2017

First Submitted That Met QC Criteria

April 26, 2017

First Posted (Actual)

May 1, 2017

Study Record Updates

Last Update Posted (Actual)

February 21, 2021

Last Update Submitted That Met QC Criteria

February 18, 2021

Last Verified

February 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cerebral Palsy

Clinical Trials on Lite Run Gait Trainer

3
Subscribe